Weiwei Chu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 10
- Reproductive Medicine top 5%
- Ovarian function and disorders 5
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Muscle Physiology and Disorders 4
- Endocrine and Autonomic Systems top 10%
- Circadian rhythm and melatonin 5
- Rehabilitation top 10%
- Wound Healing and Treatments 4
-
- Hair Growth and Disorders 5
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Weiwei Chu
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 471
- Reproductive Medicine 172
- Molecular Biology 693
- Endocrine and Autonomic Systems 55
- Rehabilitation 43
Countries citing papers authored by Weiwei Chu
This map shows the geographic impact of Weiwei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Chu more than expected).
Fields of papers citing papers by Weiwei Chu
This network shows the impact of papers produced by Weiwei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Chu. The network helps show where Weiwei Chu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiwei Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 14 | |
| 10 | 2022 | 18 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 18 | |
| 13 | 2020 | 47 | |
| 14 | 2016 | 1 | |
| 15 | 2016 | 20 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 13 | |
| 18 | 2015 | 21 | |
| 19 | 2015 | 29 | |
| 20 | 2014 | 9 |
About Weiwei Chu
Weiwei Chu is a scholar working on Cancer Research, Rehabilitation and Urology, having authored 71 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (10 papers), RNA modifications and cancer (6 papers), Hair Growth and Disorders (5 papers), Ovarian function and disorders (5 papers), Circadian rhythm and melatonin (5 papers), Muscle Physiology and Disorders (4 papers) and Wound Healing and Treatments (4 papers). The work is most often cited by research in Cancer Research (471 citations), Reproductive Medicine (172 citations) and Molecular Biology (693 citations). Weiwei Chu has collaborated with scholars based in China, United States and France. Frequent co-authors include Yanzhi Du, Zi‐Jiang Chen, Baolei Lv, Yaxiao Zhang, Xiaojian Zhao, Renfeng Wang, Qiang Zhen, Shang Li, Lina Gao and Junyu Zhai. Their work appears in journals such as Scientific Reports, Cell Proliferation, Gene, Frontiers in Oncology and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.